Navigation Links
LCT and Otsuka of Japan Share Common DIABECELL(R) Vision
Date:4/12/2011

ities to work together with Otsuka to develop our product for the treatment of diabetes in Japan and Asia, potentially one of the most significant markets for us globally. Such an arrangement augments the ongoing development progress of LCT's activities around the world.

"This is consistent with our global development and commercialisation strategy for DIABECELL. We will begin planning for a clinical trial in Japan, which will be a natural and exciting extension to our Phase II trial in New Zealand, which is coming to conclusion. To add this new jurisdiction to our clinical trial program will add important new data and significantly enhance our ability to advance DIABECELL to market."

LCT Managing Director and CEO Dr Ross Macdonald added: "The Otsuka name is widely recognised and respected in Japan and around the world for the quality healthcare products it develops and we are very pleased to be partnering with such a strong healthcare group."

Otsuka Managing Director Hiromi Yoshikawa said: "The work that LCT has been conducting into new treatments for diabetes is very significant and we are excited by the opportunities DIABECELL offers for the Asian market. We share a common vision for the treatment of diabetes and related complications. We see DIABECELL as a very significant opportunity to improve treatment options available in Japan and elsewhere in the world."

The Investment will be structured in two placement tranches as follows:

Tranche 1:

$2,280,000 payable for 19,000,000 Shares to be issued as soon as practicable after receipt of the funds, which funds must be received by LCT not later than 22 April 2011; and

Tranche 2:

$720,000, which funds must be also be received by LCT not later than 22 April 2011, for an unsecured Mandatorily Converting Note, the conversion of which is conditional upon shareholder approval to be obtained at an LCT General Meeting to be called as soon as practicable and no later t
'/>"/>

SOURCE LCT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
2. Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration
3. BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Aribex and IDENS Donate 15 Victim I.D. Kits for Japan
6. Volcano Announces the Introduction of the PrimeWire PRESTIGE® Pressure Guide Wire in Japan
7. MSA Increases Production of Air-Purifying Respirators to Help Meet Increased Demand from Japan
8. PromiseCare Pharmacy Donates to Soles4Souls® Japanese Relief Efforts
9. Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes
10. Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Valeant Pharmaceuticals International, Inc. (NYSE: ... that the company,s Bridgewater, New Jersey ... Food and Drug Administration (FDA) relating to an inspection ... to Sculptra Aesthetic injectable, which was divested to Galderma ... management of Valeant,s contract manufacturers (rather than Valeant,s own ...
(Date:9/30/2014)... 30, 2014 The Eastern European medical device ... providers as well as new medical-device manufacturers are constantly ... looking at ways to reduce the cost incurred for ... one of the effective means to achieve this target. ... in Eastern European and provides profiles of key distributors ...
(Date:9/30/2014)... Sept. 30, 2014   Decision Resources Group ... data, anemic chronic kidney disease non-dialysis (CKD-ND) patients ... (ESA) medication. In addition, one-year persistency is similar ... Other key findings from the report entitled ... of Erythropoiesis Stimulating Agents in Late Stage Chronic ...
Breaking Medicine Technology:Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3
... on 01/05/2012 of Santa Barbara physician Dr. Julio Diaz ... overdose deaths from prescription medications. According to one of ... centers, Dr. Diaz,s arrest points to the dangers both ... of finding a physician who will prescribe medication for ...
... PHILADELPHIA, January 10, 2012 Shire plc (LSE: ... company, announced today that it has acquired the rights to ... States (US) in an agreement  with Janssen Pharmaceutica N.V.  Terms ... a prokinetic, is part of Shire,s gastrointestinal (GI) portfolio in ...
Cached Medicine Technology:Arrest of California Doctor Coincides with Uptick in Prescription Drug Overdoses 2Shire Acquires US Rights to Resolor® (prucalopride) 2Shire Acquires US Rights to Resolor® (prucalopride) 3Shire Acquires US Rights to Resolor® (prucalopride) 4
(Date:9/30/2014)... News) -- There,s no genetic evidence that high levels ... new study says. Some previous research had suggested ... against type 2 diabetes, raising the possibility of a ... disease. In this study, British researchers investigated the ... on genes that control blood levels of vitamin D. ...
(Date:9/30/2014)... for doctors to measure damaging "brain tsunamis" in ... a step closer to reality, thanks to pioneering ... Institute. , The research team, led by Jed ... of neurosurgery at the UC College of Medicine, ... through an injured brain like tsunami wavescan be ...
(Date:9/30/2014)... 30, 2014 Keystone Symposia will convene the first ... its 2014-15 Global Health Series on "The Modes ... Hotel immediately following the conclusion of the Grand ... is part of the Keystone Symposia Global Health Series, ... has also funded travel awards for 36 investigators from ...
(Date:9/30/2014)... Federally Qualified Health Centers (FQHCs) granted new ... at higher rates than other primary care practices ... according to results of a new 10-state University ... Medical Care . , Using data from a ... 2013, the investigators found that FQHCs community ...
(Date:9/30/2014)... EverStryke , the permanent match currently offered by ... a free book and class all about survival education and ... investigative review. , “Joe Marshall of SurvivalLife.com is one ... niche, and this product is an excellent way to get ... that Joe offers on his website to help people be ...
Breaking Medicine News(10 mins):Health News:Gene Study Finds No Proof Vitamin D Guards Against Type 2 Diabetes 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 3Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2
... research published in the December issue of the ... that the American College of Surgeons National Surgical Quality ... assessing outcomes of uncommon, high-risk surgical procedures, including pancreatic ... on this particular procedure has been available and analyzed, ...
... finding a cure for amyotrophic lateral sclerosis (ALS, or ... to help more researchers identify treatment candidates that increase ... The Jackson Laboratory will provide the most widely used ... work with them, to researchers participating in the Prize4Life ...
... ... getting recommended eye exam; EyeSmart: EyeCommitted social media campaign seeks to reduce the largest ... ... more new cases of legal blindness among working-age Americans than any other disease. If ...
... , ST. LOUIS, Dec. 10 Centene Corporation (NYSE: ... release its 2010 financial guidance at approximately 6:00 AM (Eastern ... call afterwards at approximately 8:30 AM (Eastern Time) to discuss ... Chief Executive Officer, and William N. Scheffel, Executive Vice President, ...
... , CINCINNATI, Dec. 10 Streamline Health Solutions, ... document workflow solutions for hospitals, today announced that St. ... Health to provide a workflow solution to ensure compliance ... (VPP) promotes effective worksite-based safety and health. St. Vincent,s ...
... ... Home Care as well as one system encompassing virtually every clinical, operational and financial aspect ... , ... 10, 2009 -- Fastrack Healthcare Systems announced today the completion of the first phase ...
Cached Medicine News:Health News:Surgical quality program is a strong tool for assessing outcomes for high-risk procedures 2Health News:Prize4Life and the Jackson Laboratory team up to fight ALS 2Health News:Prize4Life and the Jackson Laboratory team up to fight ALS 3Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 2Health News:Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam 3Health News:Centene Corporation to Provide 2010 Financial Guidance On January 8, 2010 2Health News:Centene Corporation to Provide 2010 Financial Guidance On January 8, 2010 3Health News:Ascension Health Hospital Awards Streamline Health Contract to Ensure OSHA Compliance 2Health News:Ascension Health Hospital Awards Streamline Health Contract to Ensure OSHA Compliance 3Health News:Ascension Health Hospital Awards Streamline Health Contract to Ensure OSHA Compliance 4Health News:Fastrack Announces Major Expansion 2Health News:Fastrack Announces Major Expansion 3
The extended lip of the lower jaw assists in placing the lower jaw underneath less-mobile menisci....
The Smith & Nephew ACUFEX DUCKLING punches are a lower-profile relation to the Duckbill, maintaining a large square bite and maximizing maneuverability....
For the specific requirements of the posterior horn of the meniscus; the short, low profile jaw facilitates working in the tight confines of the posterior aspect of the knee....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
Medicine Products: